Close

Amarin (AMRN) Vascepa Growth Continues; Sees Limited Negative Read-Through from Merck's HPS2-THRIVE

Go back to Amarin (AMRN) Vascepa Growth Continues; Sees Limited Negative Read-Through from Merck's HPS2-THRIVE
Amarin Corp Plc (NASDAQ: AMRN) Delayed: 0.88 --0 (-0%)
Previous Close $0.88    52 Week High $3.65 
Open $0.88    52 Week Low $1.24 
Day High $0.89    P/E N/A 
Day Low $0.87    EPS $0.00 
Volume 667,287